Additionally the company has reported that it has changed its name from Axela Biosensors to Axela, to reflect the broad range of applications and markets served by its technology beyond traditional biosensing. Axela has established operations in a GMP/GLP facility in Foster City, California to accelerate the development of real time multiplex immunoassay kits for the dotLab System.
Rocky Ganske, CEO of Axela, said: “The issuance of this patent further reinforces the strong intellectual property position Axela has established in the use of diffractive optics to significantly improve the performance of immunoassays in research and diagnostic applications.”